Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119361182 | 11936118 | 2 | F | 20151026 | 20160616 | 20160121 | 20160726 | PER | US-AMGEN-USASL2015122685 | AMGEN | 57.00 | YR | A | F | Y | 0.00000 | 20160726 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119361182 | 11936118 | 1 | PS | KYPROLIS | CARFILZOMIB | 1 | Unknown | UNK | U | 202714 | INTRAVENOUS INFUSION | ||||||||
| 119361182 | 11936118 | 2 | SS | KYPROLIS | CARFILZOMIB | 1 | Unknown | DOSES ON WEEKS 1 AND 2 AND THEN OFF FOR WEEK 3 | U | 202714 | INTRAVENOUS INFUSION | ||||||||
| 119361182 | 11936118 | 3 | SS | KYPROLIS | CARFILZOMIB | 1 | Unknown | 40 MG/M2 | U | 202714 | 40 | MG/M**2 | INTRAVENOUS INFUSION | ||||||
| 119361182 | 11936118 | 4 | SS | NEUPOGEN | FILGRASTIM | 1 | Unknown | UNK | U | 0 | UNKNOWN FORMULATION | ||||||||
| 119361182 | 11936118 | 5 | SS | NEUPOGEN | FILGRASTIM | 1 | U | 0 | UNKNOWN FORMULATION | ||||||||||
| 119361182 | 11936118 | 6 | C | REVLIMID | LENALIDOMIDE | 1 | Oral | 15 MG, QD (DOSED 21 DAYS ON, 7 DAYS OFF) | 0 | 15 | MG | QD | |||||||
| 119361182 | 11936118 | 7 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | 0 | |||||||||||
| 119361182 | 11936118 | 8 | C | LEVAQUIN | LEVOFLOXACIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119361182 | 11936118 | 1 | Plasma cell myeloma |
| 119361182 | 11936118 | 4 | White blood cell count |
| 119361182 | 11936118 | 5 | White blood cell count decreased |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119361182 | 11936118 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119361182 | 11936118 | Blood potassium abnormal | |
| 119361182 | 11936118 | Blood urine present | |
| 119361182 | 11936118 | Dyspnoea | |
| 119361182 | 11936118 | Fatigue | |
| 119361182 | 11936118 | Hypertension | |
| 119361182 | 11936118 | Malaise | |
| 119361182 | 11936118 | Plasma cell myeloma | |
| 119361182 | 11936118 | Platelet count decreased | |
| 119361182 | 11936118 | Protein urine present | |
| 119361182 | 11936118 | Pyrexia | |
| 119361182 | 11936118 | Tooth disorder | |
| 119361182 | 11936118 | White blood cell count decreased | |
| 119361182 | 11936118 | White blood cell count increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 119361182 | 11936118 | 3 | 2015 | 0 | ||
| 119361182 | 11936118 | 4 | 20151105 | 0 |